Charles River Laboratories International, Inc. (CRL) Financial Statements (2023 and earlier)
Company Profile
Business Address |
251 BALLARDVALE ST WILMINGTON, MA 01887 |
State of Incorp. | |
Fiscal Year End | December 31 |
Industry (SIC) | 8731 - Commercial Physical and Biological Research (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)Annual | Quarterly
9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 195 | 201 | 243 | 242 | 214 | 224 | 466 | ||
Cash and cash equivalents | 194 | 200 | 242 | 241 | 213 | 223 | 465 | ||
Short-term investments | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||
Restricted cash and investments | 1 | 6 | 0 | 4 | 4 | 3 | 4 | ||
Receivables | 778 | 755 | 707 | 650 | 660 | 644 | 611 | ||
Inventory, net of allowances, customer advances and progress billings | 262 | 257 | 221 | 199 | 182 | 194 | 194 | ||
Inventory | 262 | 257 | 221 | 199 | 182 | 194 | 194 | ||
Prepaid expense | 92 | 81 | 90 | 94 | 78 | 85 | 82 | ||
Disposal group, including discontinued operation | 140 | ||||||||
Other undisclosed current assets | 87 | 93 | 71 | 85 | 102 | 118 | 67 | ||
Total current assets: | 1,415 | 1,393 | 1,333 | 1,274 | 1,379 | 1,268 | 1,423 | ||
Noncurrent Assets | |||||||||
Finance lease, right-of-use asset | 30 | 32 | 31 | ||||||
Operating lease, right-of-use asset | 373 | 382 | 305 | 293 | 285 | 277 | 198 | ||
Intangible assets, net (including goodwill) | 3,744 | 3,893 | 3,716 | 3,773 | 3,836 | 3,597 | 2,686 | ||
Goodwill | 2,776 | 2,860 | 2,696 | 2,712 | 2,736 | 2,540 | 1,891 | ||
Intangible assets, net (excluding goodwill) | 968 | 1,032 | 1,020 | 1,061 | 1,100 | 1,057 | 796 | ||
Deferred income tax assets | 40 | 42 | 43 | 40 | 41 | 32 | 35 | ||
Other noncurrent assets | 430 | 436 | 357 | 353 | 341 | 358 | 349 | ||
Other undisclosed noncurrent assets | 1,381 | 1,383 | 1,322 | 1,291 | 1,146 | 1,157 | 1,086 | ||
Total noncurrent assets: | 5,967 | 6,136 | 5,742 | 5,750 | 5,679 | 5,452 | 4,386 | ||
TOTAL ASSETS: | 7,383 | 7,529 | 7,075 | 7,024 | 7,058 | 6,720 | 5,809 | ||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities | 626 | 660 | 618 | 673 | 596 | 563 | 490 | ||
Accounts payable | 182 | 211 | 226 | 198 | 128 | 111 | 127 | ||
Accrued liabilities | 197 | 199 | 227 | 229 | 245 | 229 | 198 | ||
Employee-related liabilities | 200 | 203 | 165 | 246 | 223 | 223 | 165 | ||
Taxes payable | 47 | 46 | |||||||
Deferred revenue | 251 | 242 | 228 | 220 | 222 | 231 | 213 | ||
Debt | 2 | 2 | 3 | 3 | 2 | 3 | 3 | ||
Other liabilities | 182 | 190 | 145 | 138 | 164 | 132 | 97 | ||
Other undisclosed current liabilities | (47) | (46) | |||||||
Total current liabilities: | 1,014 | 1,048 | 994 | 1,033 | 984 | 930 | 803 | ||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation, including: | 2,937 | 2,997 | 2,676 | 2,664 | 2,893 | 2,727 | 2,202 | ||
Finance lease, liability | 25 | 26 | 26 | 26 | |||||
Operating lease, liability | 369 | 366 | 264 | 253 | 244 | 239 | 173 | ||
Other undisclosed long-term debt and lease obligation | 2,568 | 2,631 | 2,412 | 2,386 | 2,623 | 2,462 | 2,003 | ||
Liabilities, other than long-term debt | 391 | 425 | 470 | 583 | 473 | 470 | 414 | ||
Deferred income tax liabilities | 196 | 230 | 231 | 240 | 259 | 263 | 207 | ||
Liability, pension and other postretirement and postemployment benefits | 75 | ||||||||
Other liabilities | 195 | 195 | 239 | 243 | 214 | 207 | 207 | ||
Business combination, contingent consideration, liability | 25 | ||||||||
Other undisclosed noncurrent liabilities | 369 | 366 | 264 | 153 | 244 | 239 | 173 | ||
Total noncurrent liabilities: | 3,697 | 3,788 | 3,410 | 3,399 | 3,610 | 3,437 | 2,789 | ||
Total liabilities: | 4,711 | 4,836 | 4,404 | 4,432 | 4,594 | 4,366 | 3,593 | ||
Temporary equity, carrying amount | 39 | 40 | 56 | 53 | 33 | 31 | 28 | ||
Stockholders' equity | |||||||||
Stockholders' equity attributable to parent | 2,627 | 2,648 | 2,610 | 2,535 | 2,427 | 2,318 | 2,184 | ||
Common stock | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||
Treasury stock, value | (38) | (38) | (34) | (40) | (40) | (36) | |||
Additional paid in capital | 1,781 | 1,761 | 1,745 | 1,718 | 1,720 | 1,691 | 1,660 | ||
Accumulated other comprehensive loss | (396) | (259) | (175) | (165) | (133) | (108) | (127) | ||
Retained earnings | 1,280 | 1,183 | 1,074 | 981 | 879 | 775 | 687 | ||
Stockholders' equity attributable to noncontrolling interest | 6 | 5 | 5 | 4 | 5 | 5 | 4 | ||
Total stockholders' equity: | 2,633 | 2,653 | 2,615 | 2,539 | 2,432 | 2,323 | 2,188 | ||
TOTAL LIABILITIES AND EQUITY: | 7,383 | 7,529 | 7,075 | 7,024 | 7,058 | 6,720 | 5,809 |
Income Statement (P&L) ($ in millions) Annual | Quarterly
9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 989 | 973 | 914 | 905 | 896 | 915 | 825 | |
Gross profit: | 989 | 973 | 914 | 905 | 896 | 915 | 825 | |
Operating expenses | (219) | (169) | (188) | (174) | (181) | (204) | (185) | |
Other undisclosed operating loss | (619) | (616) | (577) | (558) | (559) | (573) | (516) | |
Operating income: | 151 | 187 | 149 | 173 | 156 | 138 | 124 | |
Nonoperating income (expense) | (16) | (40) | (42) | 20 | (16) | 6 | (44) | |
Investment income, nonoperating | 0 | 0 | (14) | 18 | 0 | 0 | (17) | |
Other nonoperating income (expense) | (17) | (40) | (29) | 2 | (16) | 6 | (28) | |
Interest and debt expense | (11) | (4) | (10) | 17 | (16) | (16) | (57) | |
Income from continuing operations before income taxes: | 123 | 144 | 96 | 210 | 123 | 127 | 23 | |
Income tax expense | (25) | (33) | (16) | (24) | (18) | (38) | (2) | |
Income before gain (loss) on sale of properties: | 98 | 111 | 80 | 186 | 105 | 90 | 20 | |
Other undisclosed net income (loss) | 15 | (46) | 44 | |||||
Net income: | 98 | 111 | 95 | 140 | 105 | 90 | 64 | |
Net loss attributable to noncontrolling interest | (1) | (1) | (2) | (2) | (2) | (1) | (2) | |
Net income available to common stockholders, diluted: | 96 | 109 | 93 | 138 | 103 | 88 | 62 |
Comprehensive Income ($ in millions)Annual | Quarterly
9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | ||
---|---|---|---|---|---|---|---|---|
Net income: | 98 | 111 | 95 | 140 | 105 | 90 | 64 | |
Other comprehensive income (loss) | (137) | (84) | (10) | 2 | (25) | 19 | ||
Other undisclosed comprehensive loss | (29) | |||||||
Comprehensive income (loss): | (39) | 27 | 85 | 113 | 80 | 109 | 64 | |
Comprehensive income (loss), net of tax, attributable to noncontrolling interest | 1 | 1 | (2) | (3) | (2) | (2) | (2) | |
Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (2) | (3) | 0 | (5) | (0) | 0 | 12 | |
Comprehensive income (loss), net of tax, attributable to parent: | (41) | 26 | 83 | 106 | 79 | 107 | 73 |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.